Stefan Kochanek

10.7k total citations · 1 hit paper
150 papers, 7.9k citations indexed

About

Stefan Kochanek is a scholar working on Molecular Biology, Genetics and Oncology. According to data from OpenAlex, Stefan Kochanek has authored 150 papers receiving a total of 7.9k indexed citations (citations by other indexed papers that have themselves been cited), including 118 papers in Molecular Biology, 95 papers in Genetics and 22 papers in Oncology. Recurrent topics in Stefan Kochanek's work include Virus-based gene therapy research (93 papers), Viral Infectious Diseases and Gene Expression in Insects (47 papers) and RNA Interference and Gene Delivery (35 papers). Stefan Kochanek is often cited by papers focused on Virus-based gene therapy research (93 papers), Viral Infectious Diseases and Gene Expression in Insects (47 papers) and RNA Interference and Gene Delivery (35 papers). Stefan Kochanek collaborates with scholars based in Germany, United States and Spain. Stefan Kochanek's co-authors include Gudrun Schiedner, Florian Kreppel, Paula R. Clemens, Robin J. Parks, Christoph Volpers, C. Thomas Caskey, Hsiao‐Huei Chen, Núria Morral, Arthur L. Beaudet and K Mitani and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Nucleic Acids Research.

In The Last Decade

Stefan Kochanek

149 papers receiving 7.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Genomic DNA transfer with a high-capacity adenovirus vector results in improved in vivo gene expression and decreased toxicity

1998 517 citations Gudrun Schiedner, Stefan Kochanek et al. profile →

Peers

Countries citing papers authored by Stefan Kochanek

Since Specialization

Citations

This map shows the geographic impact of Stefan Kochanek's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stefan Kochanek with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stefan Kochanek more than expected).

Fields of papers citing papers by Stefan Kochanek

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stefan Kochanek. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stefan Kochanek. The network helps show where Stefan Kochanek may publish in the future.

Co-authorship network of co-authors of Stefan Kochanek

This figure shows the co-authorship network connecting the top 25 collaborators of Stefan Kochanek. A scholar is included among the top collaborators of Stefan Kochanek based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stefan Kochanek. Stefan Kochanek is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	General loss of proteostasis links Huntington disease to Cockayne syndrome 2024 ·Neurobiology of Disease ·Maximilian Wagner, (unknown), (unknown), (unknown), Pallab Maity, (unknown), (unknown), Sebastian Wiese, Katrin S. Lindenberg, (unknown), G. Bernhard Landwehrmeyer, Marianna Penzo, Stefan Kochanek, Karin Scharffetter‐Kochanek, Medhanie Mulaw, Sebastian Iben	2
2	Reduction of pathological retinal neovascularization, vessel obliteration, and artery tortuosity by PEDF protein in an oxygen‐induced ischemic retinopathy rat model 2024 ·FASEB BioAdvances ·(unknown), Alexander Tschulakow, (unknown), (unknown), Stefan Kochanek, Ulrich Schraermeyer, Sylvie Julien	1
3	Evaluation of Human Mesenchymal Stromal Cells as Carriers for the Delivery of Oncolytic HAdV-5 to Head and Neck Squamous Cell Carcinomas 2023 ·Viruses ·(unknown), Lea Krutzke, (unknown), Markus Rojewski, Philip H. Zeplin, W. Funk, Hubert Schrezenmeier, Stefan Kochanek, (unknown)	3
4	Human Monocytes Are Suitable Carriers for the Delivery of Oncolytic Herpes Simplex Virus Type 1 In Vitro and in a Chicken Embryo Chorioallantoic Membrane Model of Cancer 2023 ·International Journal of Molecular Sciences ·(unknown), Lea Krutzke, Massimiliano Cadamuro, (unknown), Jens von Einem, Stefan Kochanek, Giorgio Palù, Cristina Parolin, Arianna Calistri	9
5	Pathological polyQ expansion does not alter the conformation of the Huntingtin-HAP40 complex 2021 ·Structure ·Bin Huang, Qiang Guo, (unknown), Jingdong Cheng, Tatjana Engler, Melanie Maurer, Alexander Pautsch, Wolfgang Baumeister, Florian Stengel, Stefan Kochanek, Rubén Fernández‐Busnadiego	14
6	Gene Therapy “Made in Germany”: A Historical Perspective, Analysis of the Status Quo, and Recommendations for Action by the German Society for Gene Therapy 2021 ·Human Gene Therapy ·Hildegard Büning, Boris Fehse, Zoltán Ivics, Stefan Kochanek, Ulrike Koehl, Christian Kupatt, Claudio Mussolino, Dirk M. Nettelbeck, Axel Schambach, Wolfgang Uckert, Ernst Wagner, Toni Cathomen, (unknown)	2
7	Heterologous Prime Boost Vaccination Induces Protective Melanoma-Specific CD8+ T Cell Responses 2020 ·Molecular Therapy — Oncolytics ·Sandra S. Ring, (unknown), (unknown), Erika Schmidt, Omar Hasan Ali, Burkhard Ludewig, Stefan Kochanek, Lukas Flatz	5
8	Chorioallantoic Membrane Tumor Model for Evaluating Oncolytic Viruses 2020 ·Human Gene Therapy ·Lea Krutzke, (unknown), (unknown), Stefan Kochanek	12
9	JunB defines functional and structural integrity of the epidermo-pilosebaceous unit in the skin 2018 ·Nature Communications ·Karmveer Singh, Emanuela Camera, Linda Krug, Abhijit Basu, Rajeev Pandey, (unknown), Meinhard Wlaschek, Stefan Kochanek, Marina Schorpp‐Kistner, Mauro Picardo, Peter Angel, Catherin Niemann, Pallab Maity, Karin Scharffetter‐Kochanek	27
10	Hexon Modification to Improve the Activity of Oncolytic Adenovirus Vectors against Neoplastic and Stromal Cells in Pancreatic Cancer 2015 ·PLoS ONE ·(unknown), Karim Benihoud, Frédéric Vigant, Christoph Q. Schmidt, Max G. Bachem, Thomas Simmet, Stefan Kochanek	17
11	Transcellular Targeting of Fiber- and Hexon-Modified Adenovirus Vectors across the Brain Microvascular Endothelial Cells In Vitro 2012 ·PLoS ONE ·Johanna P. Laakkonen, Tatjana Engler, Ignacio A. Romero, Babette B. Weksler, Pierre‐Olivier Couraud, Florian Kreppel, Stefan Kochanek	10
12	CAP, a new human suspension cell line for influenza virus production 2012 ·Applied Microbiology and Biotechnology ·Yvonne Genzel, Ilona Behrendt, (unknown), Erdmann Rapp, (unknown), Stefan Kochanek, Gudrun Schiedner, Udo Reichl	37
13	Chromosomal Integration of Adenoviral Vector DNA In Vivo 2010 ·Journal of Virology ·Sam L. Stephen, Eugenio Montini, (unknown), (unknown), Hans A. Kestler, Milton J. Finegold, Markus Grompe, Stefan Kochanek	60
14	Adenovirus Vector Production and Purification 2010 ·Current Gene Therapy ·Ana Carina Silva, Cristina Peixoto, (unknown), (unknown), Pedro E. Cruz, Paula M. Alves, Stefan Kochanek	27
15	Recombinant retrovirus‐like particle forming DNA vaccines in prime‐boost immunization and their use for hepatitis C virus vaccine development 2009 ·The Journal of Gene Medicine ·Delphine Desjardins, Christophe Huret, Charlotte Dalba, Florian Kreppel, Stefan Kochanek, François–Loïc Cosset, Frédéric Tangy, David Klatzmann, Bertrand Bellier	25
16	Recombinant complexes of antigen with stress proteins are potent CD8 T-cell-stimulating immunogens 2008 ·Journal of Molecular Medicine ·Andreas Wieland, (unknown), Erika Schmidt, Stefan Kochanek, Florian Kreppel, Jörg Reimann, Reinhold Schirmbeck	18
17	Fully Detargeted Polyethylene Glycol-coated Adenovirus Vectors Are Potent Genetic Vaccines and Escape from Pre-existing Anti-adenovirus Antibodies 2007 ·Molecular Therapy ·Andreas Wortmann, (unknown), Tatjana Engler, (unknown), Reinhold Schirmbeck, Jörg Reimann, Stefan Kochanek, Florian Kreppel	86
18	Increased Efficacy and Safety in the Treatment of Experimental Liver Cancer with a Novel Adenovirus-Alphavirus Hybrid Vector 2006 ·Cancer Research ·(unknown), Juan R. Rodríguez-Madoz, Pilar Alzuguren, (unknown), M. Gabriela Kramer, Stefan Kochanek, Jesús Prìeto, Cristian Smerdou, Cheng Qian	28
19	Early Adenoviral Gene Expression Mediates Immunosuppression by Transduced Dendritic Cell (DC): Implications for Immunotherapy Using Genetically Modified DC 2004 ·The Journal of Immunology ·Andrea Tuettenberg, Helmut Jonuleit, Thomas Tüting, Jürgen Brück, (unknown), Stefan Kochanek, Jürgen Knop, Alexander Enk	12
20	Pseudoachondroplasia is caused through both intra- and extracellular pathogenic pathways 2002 ·Journal of Clinical Investigation ·Robert Dinser, Frank Zaucke, Florian Kreppel, Kjell Hultenby, Stefan Kochanek, Mats Paulsson, Patrik Maurer	52

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact